Skip to main navigation Skip to main content
  • KSCN
  • E-Submission

CNR : Clinical Nutrition Research

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

3
results for

"Ezatollah Fazeli Moghadam"

Article category

Keywords

Publication year

Authors

"Ezatollah Fazeli Moghadam"

Original Article

Effects of propolis supplementation on blood glucose and lipid profiles in individuals with metabolic syndrome and type 2 diabetes: a systematic review and meta-analysis
Ezatollah Fazeli Moghadam, Elham Afshari, Leili Khaghani, Parivash Shekarchizadeh-Esfahani
Clin Nutr Res 2026;15(1):45-54.   Published online January 31, 2026
DOI: https://doi.org/10.7762/cnr.2025.0004

Objective

Propolis has been suggested as a complementary therapy for improving glycemic control and lipid metabolism. However, evidence from clinical trials remains inconsistent. This systematic review and meta-analysis aimed to provide a clear and updated assessment of the effects of propolis supplementation on fasting blood sugar (FBS) and lipid profiles in individuals with type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS).
Methods
A comprehensive search was conducted on the PubMed, Scopus, Cochrane Library, and Web of Science databases through December 2024 to identify randomized controlled trials (RCTs) evaluating the impact of propolis supplementation on FBS and lipid parameters. Eligible data were pooled using a random-effects model, and weighted mean differences (WMDs) were calculated as pooled effect sizes.
Results
A total of 12 RCTs were included, encompassing 736 participants. Propolis supplementation significantly reduced FBS (WMD, −12.08 mg/dL; 95% confidence interval [CI], −19.13 to −5.04; P=0.001) and triglyceride (TG) levels (WMD, −25.40 mg/dL; 95% CI, −44.21 to −6.59; P=0.008) without significantly affecting the levels of total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol.
Conclusion
These findings suggest that propolis supplementation may modestly improve glycemic control and reduce TG levels in individuals with T2DM and MetS. However, the limited number of available studies and relatively small sample sizes highlight the need for large, high-quality RCTs to verify these findings and clarify the metabolic effects of propolis.
  • 518 View
  • 10 Download
Review Articles
Effects of Almond Consumption on Selected Markers of Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis
Maryam Eslami, Leili Khaghani, Ezatollah Fazeli Moghadam
Clin Nutr Res 2025;14(1):78-89.   Published online January 31, 2025
DOI: https://doi.org/10.7762/cnr.2025.14.1.78

This systematic review and meta-analysis aimed to evaluate the effectiveness of almond consumption on serum C-reactive protein (CRP) and malondialdehyde (MDA) levels in individuals at risk of cardiovascular disease (CVD). An electronic database search was performed on PubMed, Web of Science, Scopus, and the Cochrane Library from inception through October 2024. Summary effect size measurements were calculated using random effects model estimation and were reported as weighted mean differences (WMDs) along with 95% confidence intervals (CIs). A total of 258 articles were identified, and 13 randomized controlled trials (RCTs) were included in the systematic review and meta-analysis. The meta-analysis of eleven RCTs, which involved a total of 544 participants, indicated that almonds significantly reduced levels of CRP (WMD, −0.28 mg/L; 95% CI, −0.52, −0.04; p = 0.02). However, we found no significant benefit of almond consumption in improving serum MDA levels, and due to the limited number of studies, the examination of MDA was conducted only qualitatively. This study supports the conclusion that almond consumption has favorable effects on CRP levels in individuals with CVD risk factors. More high-quality trials are needed to confirm these findings.

Citations

Citations to this article as recorded by  
  • Daily Almond Supplementation Improves Blood Pressure and Lipid Profile in Pregnant Women with Hypertension and Dyslipidemia: A Randomized Controlled Trial
    Jamshed Arslan, Zainab Najam, Hamza Abdullah, Hasan Salman Siddiqi, Raffat Bano, Anwar-ul-Hassan Gilani, Humaira Jamshed
    The Journal of Nutrition.2026; 156(2): 101270.     CrossRef
  • 1,005 View
  • 1 Download
  • 1 Crossref
Flaxseed Lowers Blood Pressure in Hypertensive Subjects: A Meta-Analysis of Randomized Controlled Trials
Ezatollah Fazeli Moghadam, Leili Khaghani, Parivash Shekarchizadeh-Esfahani
Clin Nutr Res 2024;13(4):295-306.   Published online October 29, 2024
DOI: https://doi.org/10.7762/cnr.2024.13.4.295

This systematic review and meta-analysis study aimed to evaluate the effectiveness of flaxseed supplementation on blood pressure (BP) in patients with hypertension based on the data from randomized clinical trials (RCTs). Three databases (PubMed [MEDLINE], Scopus, and ISI Web of Science) were searched from inception up to August 10, 2024. Relevant studies meeting our eligibility criteria were obtained. A random-effects model was used to estimate pooled weighted mean differences (WMDs) with 95% confidence intervals (CIs). The methodological quality of individual studies was assessed using the Cochrane Collaboration risk of bias tool. A total of 5 studies were included and analyzed using STATA software version 12. The results show that there is a significant decrease in systolic BP (WMD, −8.64 mmHg; 95% CI, −15.41 to −1.87; p ≤ 0.001) and diastolic BP (WMD, −4.87 mmHg; 95% CI, −8.37 to −1.37; p = 0.006) of patients with hypertension as compared to control groups. This study supported that flaxseed supplementation had favorable effects on BP control in hypertensive patients. It may be a promising adjuvant therapy for patients with hypertension.

Citations

Citations to this article as recorded by  
  • Albumin-Bound Fatty Acids Modulate Endogenous Angiotensin-Converting Enzyme (ACE) Inhibition
    Enikő Edit Enyedi, Attila Ádám Szabó, Tamás Bence Pintér, Ivetta Siket Mányiné, Anna Pluhár, Csongor Váradi, Emese Bányai, Attila Tóth, Zoltán Papp, Miklós Fagyas
    Biomedicines.2026; 14(1): 103.     CrossRef
  • Molecular Mechanisms of Lignans in Lowering Blood Pressure and Anti-Obesity Effects: A Review
    Gitishree Das, Sandra Gonçalves, José Basilio Heredia, Nayely Leyva-López, Anabela Romano, Spiros Paramithiotis, Han-Seung Shin, Jayanta Kumar Patra
    Foods.2026; 15(2): 336.     CrossRef
  • Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging
    Setor K. Kunutsor, Davinder S. Jassal, Amir Ravandi, Andrea Lehoczki
    GeroScience.2025; 47(3): 2895.     CrossRef
  • 1,558 View
  • 10 Download
  • 3 Crossref